SELARSDI 45 mg/.5mL Injection, Solution
Also known as Ustekinumab-Aekn. Coverage in Oregon and Washington (CMS PDP Region 30).
2 of 10 stand-alone Part D plans in Oregon and Washington cover this drug on tier 3.
2 of 2 plans apply a prior authorization, step therapy or quantity limit.
24 Medicare Advantage plans in OR, WA do cover it
Medicare Advantage plans carry their own formularies, separate from stand-alone Part D. A patient on an MA-PD plan may have coverage even where no PDP lists the drug. OR: 15 plans · WA: 9 plans.
Every plan that covers it
| Plan | Tier | 30-day preferred | 90-day mail | Unit cost | Est. 30-day fill | Restrictions |
|---|---|---|---|---|---|---|
| HealthSpring Assurance Rx (PDP)$0.00/mo premium · $615.00 deductible | 3Preferred Brand | 24% | 24% | $3980.3964 | $2,149.410.54 units |
|
| HealthSpring Extra Rx (PDP)$50.00/mo premium · $615.00 deductible | 3Preferred Brand | 16% | 16% | $3979.8589 | $2,149.120.54 units |
|
Cost-sharing is the initial coverage phase at a preferred pharmacy; a percentage is coinsurance of the plan’s negotiated price, and the deductible may apply first. CMS publishes a negotiated price per unit, so the 30-day fill is shown only where the plan’s own quantity limit supplies the quantity.